Kelleher Financial Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.77M Buy
10,320
+515
+5% +$120K 0.45% 43
2025
Q4
$2.03M Sell
9,805
-84
-0.8% -$16.6K 0.47% 44
2025
Q3
$1.83M Buy
9,889
+25
+0.3% +$4.28K 0.46% 43
2025
Q2
$1.51M Buy
9,864
+2,022
+26% +$311K 0.52% 31
2025
Q1
$1.3M Buy
7,842
+1,326
+20% +$207K 0.52% 32
2024
Q4
$942K Buy
6,516
+165
+3% +$25.6K 0.36% 36
2024
Q3
$1.03M Buy
6,351
+102
+2% +$16.3K 0.39% 34
2024
Q2
$913K Sell
6,249
-1,861
-23% -$277K 0.38% 36
2024
Q1
$1.28M Buy
8,110
+1,397
+21% +$222K 0.53% 28
2023
Q4
$1.05M Buy
6,713
+3
+0% +$460 0.49% 29
2023
Q3
$1.05M Buy
6,710
+7
+0.1% +$1.16K 0.54% 29
2023
Q2
$1.11M Buy
6,703
+1,538
+30% +$248K 0.64% 26
2023
Q1
$801K Sell
5,165
-1,347
-21% -$218K 0.53% 35
2022
Q4
$1.15M Buy
6,512
+3
+0% +$518 0.86% 23
2022
Q3
$1.06M Sell
6,509
-3,487
-35% -$590K 0.76% 27
2022
Q2
$1.77M Buy
9,996
+3,492
+54% +$622K 0.8% 22
2022
Q1
$1.15M Buy
6,504
+3
+0% +$510 0.64% 28
2021
Q4
$1.11M Sell
6,501
-3,362
-34% -$550K 0.59% 32
2021
Q3
$1.59M Buy
9,863
+3,276
+50% +$559K 0.7% 31
2021
Q2
$1.08M Buy
6,587
+2
+0% +$331 0.61% 28
2021
Q1
$1.08M Buy
6,585
+3
+0% +$485 0.69% 28
2020
Q4
$1.03M Sell
6,582
-316
-5% -$46.6K 0.78% 24
2020
Q3
$1.03M Buy
6,898
+2
+0% +$296 0.85% 24
2020
Q2
$969K Buy
6,896
+3
+0% +$437 0.93% 24
2020
Q1
$903K Buy
6,893
+441
+7% +$62.6K 1.08% 20
2019
Q4
$941K Sell
6,452
-88
-1% -$11.9K 0.95% 25
2019
Q3
$846K Buy
6,540
+2
+0% +$263 1.03% 20
2019
Q2
$910K Buy
+6,538
New +$905K 1.12% 21
2018
Q4
$853K Buy
6,612
+2
+0% +$279 1.37% 16
2018
Q3
$913K Buy
6,610
+362
+6% +$48.1K 1.19% 17
2018
Q2
$758K Buy
6,248
+3
+0% +$374 1.08% 23
2018
Q1
$800K Buy
6,245
+2
+0% +$270 1.09% 20
2017
Q4
$872K Buy
+6,243
New +$870K 1.38% 18
2017
Q1
Sell
-11,859
Closed -$1.37M 108
2016
Q4
$1.37M Buy
11,859
+134
+1% +$15.5K 0.76% 41
2016
Q3
$1.39M Sell
11,725
-300
-2% -$36.4K 0.78% 39
2016
Q2
$1.46M Sell
12,025
-3,642
-23% -$414K 0.88% 39
2016
Q1
$1.7M Buy
15,667
+3,942
+34% +$408K 0.93% 36
2015
Q4
$1.2M Hold
11,725
0.82% 39
2015
Q3
$1.09M Hold
11,725
0.73% 42
2015
Q2
$1.14M Sell
11,725
-700
-6% -$70.1K 0.65% 44
2015
Q1
$1.25M Sell
12,425
-966
-7% -$98.2K 0.69% 42
2014
Q4
$1.4M Hold
13,391
0.75% 42
2014
Q3
$1.44M Hold
13,391
0.78% 41
2014
Q2
$1.4M Hold
13,391
0.73% 41
2014
Q1
$1.31M Hold
13,391
0.71% 40
2013
Q4
$1.23M Hold
13,391
0.63% 43
2013
Q3
$1.16M Sell
13,391
-1,040
-7% -$93.3K 0.66% 44
2013
Q2
$1.24M Buy
+14,431
New +$1.22M 0.76% 43

Other funds holding JNJ

Kelleher Financial Advisors's JNJ Position: Q1 2026 in Review

Kelleher Financial Advisors increased its Johnson & Johnson (JNJ) stake by 5.3% in Q1 2026, buying an estimated $120K and bringing the position to 10,320 shares worth $1.77M. The position accounts for 0.45% of the portfolio, ranked #43.

Kelleher Financial Advisors first reported a position in JNJ in Q2 2013 and has held it in 48 quarters since. The position peaked at $2.03M in Q4 2025. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Kelleher Financial Advisors held 10,320 shares of Johnson & Johnson worth $1.77M as of Q1 2026.
  • Kelleher Financial Advisors bought 515 Johnson & Johnson shares in Q1 2026, an estimated $120K.
  • Johnson & Johnson made up 0.45% of Kelleher Financial Advisors's portfolio in Q1 2026, its #43 holding.
  • Kelleher Financial Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 48 quarters since.
  • Kelleher Financial Advisors's Johnson & Johnson position peaked at $2.03M in Q4 2025.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Kelleher Financial Advisors's 13F filing for Q1 2026, filed 8 May 2026.